HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

Where Did Cortina Holdings Cash Go In Half Year 2025/26

5 Surprising Insights from Cortina's Latest Financial Report The latest half-year report from luxury watch...
SGX-LISTED COMPANIES

Revenue Is Growing, Yet Losses Are Deepening For Heatec Jietong Holdings In Q3 2025

5 Surprising Insights from Heatec Jietong Holdings Q3 Financial Report 1. Revenue is Growing, But...
SGX-LISTED COMPANIES

Rich Capital Holdings Went From Loss To Profit In 1H 2025/26

How a S$1 Million Gain Masks a 75% Revenue Collapse at Rich Capital Introduction: The...
SGX-LISTED COMPANIES

Frasers Logistics & Commercial Trust FY2025 — Revenue’s Up… So Why Are Payouts Down?

Frasers Logistics & Commercial Trust's Revenue is Up, So Why Are Payouts Down? 4...
SGX-LISTED COMPANIES

Powermatic Data Systems Half-Year 2025/26: Europe & US Sales Dip As Asia Surges

5 Surprising Truths Hidden in a Tech Company's Financial Report Introduction: This article dives into the...
SGX-LISTED COMPANIES

OCBC Q3 2025 Profit Saved By Wealth Management

Behind OCBC's Flat Profit: A Banking Engine in Transition At first glance, OCBC's third-quarter 2025...
SGX-LISTED COMPANIES

Globe Life’s Strong Momentum Continues In Q3 2025

Here Are The 5 Most Surprising Takeaways From Globe Life's 100-Page Quarterly Report Corporate financial...
SGX-LISTED COMPANIES

Doubts On OxPay Financial’s Future After Q3 2025

OxPay's Revenue Is Up 21%. So Why Is It Fighting for Survival? Introduction Singapore-based payment solutions...
SGX-LISTED COMPANIES

How SunMoon Food Company Achieved A Major Turnaround In Their Half-Year 2025/26

SunMoon Food's Gross Profit Soared 216%—But The Real Story Is More Complex Corporate financial reports...
SGX-LISTED COMPANIES

Charisma Energy Services Goes From Net Liability To Net Asset Gold In Q3 2025

From a $50 Million Deficit to a $41 Million Profit: The Incredible Turnaround Hiding...
SGX-LISTED COMPANIES

DBS Delivers A Record Q3 2025

DBS Just Reported Record Earnings. Here’s What the Numbers Really Say This week, DBS Group...
SGX-LISTED COMPANIES

Bukit Sembawang Estates Revenue Drops 60% For Half-Year 2025/26

This Property Giant's Revenue Fell 60%—Here Are 5 Reasons It's Actually a Sign of...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...